OliX Pharmaceuticals
About:
OliX is a clinical stage biotechnology company.
Website: http://olixpharma.com
Twitter/X: OliXPharmaceut1
Top Investors: IMM Investment, Kiwoom Investment, Company K Partners, Aju IB Investment, NH Investment & Securities
Description:
OliX is a clinical stage biotechnology company, based on their own proprietary RNA interference (RNAi) technology regulating the expression of disease-causing genes.
Total Funding Amount:
41.5B KRW
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Suwon, Ch'ungch'ong-namdo, South Korea
Founded Date:
2010-02-26
Contact Email:
olixpharma(AT)olixpharma.com
Founders:
Dong-ki Lee
Number of Employees:
51-100
Last Funding Date:
2020-12-01
IPO Status:
Public
Industries:
© 2025 bioDAO.ai